Page last updated: 2024-09-04

olmesartan and Lymphocytic Colitis

olmesartan has been researched along with Lymphocytic Colitis in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Heinrich, C; Zimmer, V1
Gonakoti, S; Khullar, S; Rajkumar, A1

Other Studies

2 other study(ies) available for olmesartan and Lymphocytic Colitis

ArticleYear
Olmesartan-induced lymphocytic colitis: a specific gap in the guideline?
    Clinics and research in hepatology and gastroenterology, 2021, Volume: 45, Issue:3

    Topics: Antihypertensive Agents; Biopsy; Colitis, Lymphocytic; Colitis, Microscopic; Colonoscopy; Diarrhea; Humans; Imidazoles; Practice Guidelines as Topic; Tetrazoles

2021
Olmesartan Associated Enteropathy: A Rare Underdiagnosed Cause of Diarrhea and Weight Loss.
    The American journal of case reports, 2019, Jan-26, Volume: 20

    Topics: Antihypertensive Agents; Colitis, Lymphocytic; Diarrhea; Humans; Imidazoles; Male; Middle Aged; Tetrazoles; Vomiting; Weight Loss

2019